Skip to search formSkip to main contentSkip to account menu

Sch-417690

Known as: SCH-D, Sch 417690, Sch417690 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Vicriviroc or SCH 417690 is a potent and selective antagonist of the CCR5 receptor. CCR5 receptor antagonists have the potential… 
2011
2011
The threshold condition in long-wavelength InAlGaAs/InP transistor lasers is theoretically and numerically investigated. The… 
2008
2008
In addition to being an important receptor in leukocyte activation and mobilization, CCR5 is the essential coreceptor for human… 
Review
2006
Review
2006
Entry inhibitors constitute a new drug class for treatment of HIV-1 infection. They are divided into subclasses, each aiming at a… 
2005
2005
Method of treating HIV infection due to the fact that both the administration of tipranavir and SCH-417690. 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Inhibiting human immunodeficiency virus type 1 (HIV-1) infection by blocking the host cell coreceptors CCR5 and CXCR4 is… 
Highly Cited
1989
Highly Cited
1989
D adc County, Florida, has made front-page headlines with its pilot School-Based Manage ment/Shared Decision Making Pro gram The…